BioElectronics Corporation
BIEL
$0.0003
$0.000150.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 94.01% | 192.83% | 171.39% | 42.76% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.01% | 192.83% | 171.39% | 42.76% | -- |
| Cost of Revenue | 151.70% | 164.35% | 150.55% | 47.77% | -- |
| Gross Profit | 57.15% | 221.49% | 193.54% | 38.67% | -- |
| SG&A Expenses | -42.67% | 16.00% | -2.91% | -7.55% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.21% | 32.78% | 12.66% | -6.19% | -- |
| Operating Income | 86.72% | 71.47% | 59.76% | 40.57% | -- |
| Income Before Tax | 75.00% | 82.14% | 68.64% | 57.99% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 75.00% | 82.14% | 68.64% | 57.99% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.00% | 82.14% | 68.64% | 57.99% | -- |
| EBIT | 86.72% | 71.47% | 59.76% | 40.57% | -- |
| EBITDA | -- | 80.94% | 66.40% | 45.45% | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 3.11% | 6.47% | 6.38% | 6.85% | -- |
| Average Diluted Shares Outstanding | 3.11% | 6.47% | 6.38% | 6.85% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |